Literature DB >> 2859797

Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise.

L H Opie.   

Abstract

During normal exercise the myocardium, skeletal muscle, liver and adipose tissue all participate in the metabolic response to exercise. Beta-blockade, by impairing this biochemical-metabolic response at several levels, limits the capacity for maximal exercise. The relevant effects of beta blockade may include hypoglycemia, impaired mobilization of free fatty acids and decreased breakdown of glycogen in skeletal muscle. The organs responsible for these metabolic changes are the liver (blood sugar), adipose tissue (blood free fatty acids) and skeletal muscle. Most of the metabolic beta-adrenergic receptors are thought to be beta 2 in nature. Two populations of receptors (mixed beta 1 and beta 2) may explain some controversial findings. Overall, the data suggest that cardioselective agents may have less effect than nonselective agents in producing metabolic impairment during sustained exercise.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859797     DOI: 10.1016/0002-9149(85)91062-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.

Authors:  S Wieshammer; M Hetzel; U Barnikel; M Höher; H Seibold; M Kochs; V Hombach
Journal:  Klin Wochenschr       Date:  1991-09-16

Review 2.  Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment.

Authors:  Oliver J Ziff; Monica Samra; James P Howard; Daniel I Bromage; Frank Ruschitzka; Darrel P Francis; Dipak Kotecha
Journal:  BMC Med       Date:  2020-05-05       Impact factor: 8.775

3.  Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice.

Authors:  Jaroslawna Meister; Derek B J Bone; Grzegorz Godlewski; Ziyi Liu; Regina J Lee; Sergey A Vishnivetskiy; Vsevolod V Gurevich; Danielle Springer; George Kunos; Jürgen Wess
Journal:  PLoS Genet       Date:  2019-10-17       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.